Blog - Page 3934 of 5389

MondayMar 23, 2009 9:06 am

Investors Enjoy Surging Stock Rally as Home Sales Rise and Government Announces Bank Plan

In afternoon trading, the Dow is up 4.40% (+320.10 points), the Nasdaq 4.15% (+59.82 points), and the S&P 500 4.53% (+34.80) following the announcement of the government’s plans to remove bad assets from banks’ books as well as a report showing a surprising increase in home sales. The Treasury Department said that the financial effort would rely on the government's $700 billion financial rescue fund, the Federal Reserve and the Federal Deposit Insurance Corp., as well as private investors. The plan is designed to draw in private investors, including big hedge funds, to participate by offering billions of dollars in…

MondayMar 23, 2009 6:55 am

GreenChek Technology (GCHK.OB) Poised To Reclaim the Environment

GreenChek Technology has a stated focus of “giving back to the environment while redesigning the future”. A lot of companies talk “green”, but GreenChek can back up everything they say. The key is a unique technology called Onboard Hydrogen Generation and Injection (OHGI), a way of using hydrogen to increase engine efficiency and greatly reduce emissions. Hydrogen has long been known as a way of improving the fuel combustion process, but a system that can generate hydrogen onsite or onboard a vehicle represents a huge step in making the benefits of hydrogen immediately available to the marketplace. Much of the…

MondayMar 23, 2009 6:51 am

CNS Response, Inc. (CNSO.OB) Awarded Third U.S. Patent Targeting the Development of New Indications for Existing Drugs

CNS Response, Inc. announced that it has received a patent from the U.S. Patent and Trademark Office. The patent, numbered 7,489,964 and titled “Electroencephalography Based Systems and Methods for Selecting Therapies and Predicting Outcomes”, extends application of rEEG® technology to novel methods that can expand indications for CNS pharmaceuticals. "One of the most compelling opportunities in pharmaceutical marketing is the ability to expand new indications for already approved medications," commented CNS Response CEO Len Brandt. "With the successful completion of our multisite study for the treatment of resistant depression, I believe we will have demonstrated the utility of the rEEG…

MondayMar 23, 2009 6:42 am

Brainstorm Cell Therapeutics Inc. (BCLI.OB) Elects Malcolm Taub to its Board of Directors

Brainstorm Cell Therapeutics Inc. today announced the election of Malcolm S. Taub to its Board of Directors. Malcolm Taub has had a distinguished career in the practice of law in New York City for 34 years. He has had a varied practice ranging from complex Federal Securities matters, fraud litigation to real estate litigation. He has been a leader in Latin American securities matters and has served as a consultant to the Argentinean Stock Exchange. His investment firm provided consultation, as well as advice with respect to bringing foreign private entities public in the United States. Mr. Taub has been…

MondayMar 23, 2009 5:38 am

China Agritech, Inc. (CAGC.OB) Management Accumulates Company Stock

China Agritech, Inc., a national liquid and granular organic compound fertilizer manufacturer and distributor in China, announced that Mr. Yu Chang, Chairman, CEO, and President of the company, and one of the directors of the company, Ms. Xiaorong Teng, have purchased shares in the open market. According to the press release, Mr. Yu Chang purchased a total of 27,012 common shares at prices ranging between $0.86 and $1.05 per share and Ms. Xiaorong Teng purchased 20,000 common shares at prices ranging between $0.86 and $1.01 per share. Mr. Yu Chang commented, "We believe we have built a successful business and…

MondayMar 23, 2009 5:26 am

MDRNA, Inc. (MRNA) Signs Worldwide Non-Exclusive Licensing Agreement for RNAi Delivery Technology

MDRNA, Inc. announced today that it has entered into a licensing agreement with Novartis for MDRNA's liposomal technology platform for siRNA delivery. According to the press release, MDRNA will receive $7.25 million in upfront fees for the non-exclusive license. The companies also entered into a separate agreement that provides Novartis with an exclusive period to negotiate a research and development collaboration and broader licensing rights related to MDRNA's RNAi drug delivery platform. J. Michael French, President and Chief Executive Officer of MDRNA, stated, "We are pleased to enter into this agreement with Novartis, a global leader in the field of…

MondayMar 23, 2009 4:36 am

Axial Vector Energy Corp. (AXVC.PK) and Adaptive Propulsion Systems Plan Technology Transfer Closing Date for April 4, 2009

Today, Axial Vector Energy Corporation announced that it has planned April 4th, 2009 as the date to formally transfer technology from Adaptive Propulsion Systems to AVEC. This transfer will allow AVEC to finally complete license agreements and Joint Ventures that have been pending the development completion for the last two years. Mr. Ahmed Khalifa, Chairman of AVEC commented, "It is a significant milestone for our Company to have outsourced completed assembly of these units and have them successfully tested. We are ready to move ahead with sales and licensing opportunities around the world knowing our revolutionary engines and generators can…

MondayMar 23, 2009 4:23 am

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Reports Noteworthy Progress in Development of Site Specific Genetic Recombination

Kraig Biocraft Laboratories, Inc. announced this morning that Dr. Fraser’s team has "made significant progress on developing enzymes and strategies for conducting site specific genetic recombination in silkworm." "In the Company's view, the development of this particular gene splicing technology is the key to unlocking the tremendous commercial potential of spider silks and other recombinant polymers," stated Kraig's CEO, Kim K. Thompson. "Dr. Fraser's report of this news from the laboratory is the culmination of years of scientific effort. It is a huge milestone on the path to commercialization," continued Thompson. "We believe that we are the only people who…

FridayMar 20, 2009 10:26 am

Kraig Biocraft Laboratories, Inc. (KBLB.OB): The Target Market for Spider Silk

The market Kraig Biocraft Laboratories has targeted is generally referred to as the "technical textiles" market. This market encompasses a wide range of products that are used for a large number of different types of applications. The products sold into the technical textiles market are either finished products in themselves or are used as components to produce other products. The specific sector of the technical textiles market targeted by the company is known as the high-performance fibers market and can be broken down into two main areas: Aramid fibers, the best known of these fibers being DuPont’s Kevlar which produces…

FridayMar 20, 2009 10:09 am

MMR Information Systems Inc. (FVRL.OB) Pushing Public Awareness of the Importance of Personal Health Records in Light of Healthcare Reform

MMR Information Systems Inc. (previously Favrille Inc.) operates through its subsidiary, MyMedicalRecords Inc. (MMR), to provide consumer-controlled Personal Health Records (PHR) and electronic safe deposit box storage solutions. The company today announced that Richard A. Gephardt, who sits on MyMedicalRecords’ board of directors, will collaborate with MMR to raise awareness of the companies’ focus on educating consumers on the importance and timeliness of setting up a PHR. PHRs give individuals more control over their health and well-being, with easy access to medical records, living wills, passports and other personal information. With the Obama Administration promising for changes in our healthcare…

Site Search

Company Search